Back to search
Cervical Large Cell Neuroendocrine Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cervical Large Cell Neuroendocrine Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cervical Large Cell Neuroendocrine Carcinoma trials you may qualify forPhase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24…
This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the corre…
Patients with digestive tract malignancy often experience severe and unremitting abdominal pain that negatively affects physical, emotional, and social function…
A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dose…
The purpose of this study is to learn about the effects of a new study medicine called PF-08046032, when taken alone and when taken with another medicine called…
This study will investigate the safety and tolerability of MAGE-A4ᶜ¹º³²T cell therapy in subjects who have the appropriate HLA-A2 tissue marker and whose urinar…